| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pneumonia, Pneumococcal | 7 | 2019 | 251 | 0.79 | Why? |
| Streptococcus pneumoniae | 11 | 2019 | 827 | 0.67 | Why? |
| Pneumococcal Infections | 4 | 2018 | 562 | 0.34 | Why? |
| Capillary Permeability | 2 | 2021 | 277 | 0.34 | Why? |
| Pneumonia, Bacterial | 3 | 2018 | 843 | 0.31 | Why? |
| Proteomics | 4 | 2021 | 2481 | 0.24 | Why? |
| Endothelial Cells | 4 | 2021 | 2048 | 0.23 | Why? |
| Streptococcus | 1 | 2002 | 76 | 0.23 | Why? |
| Brain Abscess | 1 | 2002 | 50 | 0.23 | Why? |
| Cadherins | 2 | 2021 | 145 | 0.21 | Why? |
| Bronchi | 2 | 2018 | 1048 | 0.21 | Why? |
| Silicones | 1 | 2019 | 26 | 0.21 | Why? |
| Sialic Acid Binding Ig-like Lectin 1 | 1 | 2021 | 156 | 0.20 | Why? |
| Myelopoiesis | 1 | 2020 | 116 | 0.20 | Why? |
| Legionella pneumophila | 2 | 2017 | 143 | 0.20 | Why? |
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2018 | 3 | 0.19 | Why? |
| Angiopoietin-1 | 1 | 2018 | 25 | 0.19 | Why? |
| Lung Diseases | 3 | 2017 | 2361 | 0.19 | Why? |
| Streptolysins | 1 | 2018 | 8 | 0.19 | Why? |
| Receptors, Lysosphingolipid | 1 | 2018 | 25 | 0.19 | Why? |
| Electric Impedance | 1 | 2021 | 283 | 0.18 | Why? |
| IgA Deficiency | 1 | 2018 | 36 | 0.18 | Why? |
| Bronchial Diseases | 1 | 2018 | 31 | 0.18 | Why? |
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2018 | 49 | 0.18 | Why? |
| Praziquantel | 1 | 2017 | 44 | 0.17 | Why? |
| Lung | 11 | 2021 | 31049 | 0.17 | Why? |
| Persistent Fetal Circulation Syndrome | 1 | 2017 | 9 | 0.17 | Why? |
| Cytological Techniques | 1 | 2018 | 79 | 0.17 | Why? |
| Toll-Like Receptor 8 | 1 | 2018 | 102 | 0.17 | Why? |
| Nucleotidyltransferases | 1 | 2018 | 77 | 0.17 | Why? |
| Cryosurgery | 1 | 2018 | 57 | 0.17 | Why? |
| TYK2 Kinase | 1 | 2017 | 116 | 0.17 | Why? |
| Communicable Diseases | 3 | 2017 | 2148 | 0.17 | Why? |
| Kruppel-Like Transcription Factors | 1 | 2018 | 91 | 0.17 | Why? |
| Endothelium | 1 | 2021 | 460 | 0.17 | Why? |
| Angiopoietin-2 | 1 | 2018 | 125 | 0.17 | Why? |
| Schistosomiasis | 1 | 2017 | 59 | 0.16 | Why? |
| Feedback, Physiological | 1 | 2016 | 56 | 0.16 | Why? |
| Inflammation | 7 | 2021 | 13255 | 0.16 | Why? |
| Anthelmintics | 1 | 2017 | 104 | 0.16 | Why? |
| Proteome | 3 | 2021 | 1812 | 0.16 | Why? |
| DNA, Mitochondrial | 1 | 2018 | 163 | 0.16 | Why? |
| Blood Proteins | 1 | 2020 | 551 | 0.16 | Why? |
| Legionnaires' Disease | 1 | 2017 | 108 | 0.15 | Why? |
| Carrier Proteins | 1 | 2019 | 513 | 0.15 | Why? |
| Granuloma | 1 | 2017 | 88 | 0.15 | Why? |
| Disease Models, Animal | 8 | 2021 | 10998 | 0.15 | Why? |
| Mice, Inbred C57BL | 7 | 2020 | 5542 | 0.15 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2018 | 260 | 0.15 | Why? |
| Anti-Bacterial Agents | 6 | 2018 | 10083 | 0.14 | Why? |
| Unnecessary Procedures | 1 | 2017 | 175 | 0.14 | Why? |
| Myeloid Cells | 1 | 2020 | 808 | 0.14 | Why? |
| Tandem Mass Spectrometry | 1 | 2021 | 1031 | 0.14 | Why? |
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 290 | 0.14 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 497 | 0.14 | Why? |
| Cardiotoxicity | 1 | 2017 | 365 | 0.13 | Why? |
| Microbial Viability | 1 | 2018 | 406 | 0.13 | Why? |
| DNA, Bacterial | 1 | 2018 | 835 | 0.13 | Why? |
| Macrophage Activation | 1 | 2016 | 315 | 0.13 | Why? |
| Alveolar Epithelial Cells | 2 | 2021 | 1445 | 0.13 | Why? |
| Pseudomonas Infections | 1 | 2018 | 425 | 0.13 | Why? |
| Macrophages, Alveolar | 1 | 2017 | 668 | 0.13 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.13 | Why? |
| Mice | 11 | 2020 | 21357 | 0.13 | Why? |
| Single-Cell Analysis | 2 | 2020 | 2450 | 0.12 | Why? |
| Host Specificity | 1 | 2017 | 926 | 0.12 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.12 | Why? |
| Macrophages | 3 | 2021 | 2784 | 0.12 | Why? |
| Malaria, Falciparum | 1 | 2017 | 377 | 0.12 | Why? |
| Lymphocyte Activation | 2 | 2020 | 2742 | 0.11 | Why? |
| Pulmonary Alveoli | 1 | 2017 | 867 | 0.11 | Why? |
| Bacteria | 1 | 2003 | 1897 | 0.11 | Why? |
| Monocytes | 2 | 2021 | 2978 | 0.11 | Why? |
| Germany | 7 | 2021 | 9196 | 0.11 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2018 | 665 | 0.11 | Why? |
| Endothelium, Vascular | 1 | 2003 | 1751 | 0.11 | Why? |
| Bacteremia | 1 | 2002 | 1372 | 0.11 | Why? |
| Respiratory System | 2 | 2021 | 3213 | 0.11 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.11 | Why? |
| Mitochondria | 1 | 2018 | 857 | 0.11 | Why? |
| Orthomyxoviridae Infections | 1 | 2018 | 1001 | 0.11 | Why? |
| Berlin | 2 | 2021 | 283 | 0.10 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.10 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.10 | Why? |
| Acute Lung Injury | 1 | 2018 | 904 | 0.10 | Why? |
| Viruses | 1 | 2003 | 2238 | 0.10 | Why? |
| Mice, Knockout | 3 | 2019 | 1815 | 0.10 | Why? |
| Animals | 16 | 2021 | 78931 | 0.09 | Why? |
| Kinetics | 3 | 2021 | 3238 | 0.09 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.09 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.08 | Why? |
| Transcriptome | 1 | 2020 | 3466 | 0.08 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.08 | Why? |
| Phagocytosis | 2 | 2019 | 409 | 0.08 | Why? |
| Blood Gas Analysis | 2 | 2021 | 893 | 0.08 | Why? |
| Gastrointestinal Microbiome | 1 | 2019 | 1961 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.08 | Why? |
| Myocardium | 1 | 2017 | 2323 | 0.07 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.07 | Why? |
| Immunity, Innate | 3 | 2018 | 6570 | 0.07 | Why? |
| Statistics, Nonparametric | 2 | 2018 | 1008 | 0.07 | Why? |
| Signal Transduction | 2 | 2021 | 7207 | 0.07 | Why? |
| Interferons | 1 | 2017 | 2885 | 0.07 | Why? |
| Humans | 43 | 2021 | 930598 | 0.07 | Why? |
| Antimalarials | 1 | 2017 | 2505 | 0.07 | Why? |
| Lung Injury | 1 | 2013 | 919 | 0.07 | Why? |
| Host-Pathogen Interactions | 3 | 2018 | 11041 | 0.06 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.06 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.06 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.06 | Why? |
| Cricetinae | 2 | 2021 | 3344 | 0.06 | Why? |
| Cell Differentiation | 2 | 2020 | 1338 | 0.06 | Why? |
| MicroRNAs | 1 | 2016 | 1787 | 0.06 | Why? |
| Community-Acquired Infections | 2 | 2017 | 2328 | 0.06 | Why? |
| Cells, Cultured | 3 | 2020 | 5835 | 0.06 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.06 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.06 | Why? |
| Occludin | 1 | 2021 | 53 | 0.06 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.06 | Why? |
| Saccharomyces cerevisiae Proteins | 1 | 2021 | 66 | 0.06 | Why? |
| Influenza A virus | 3 | 2018 | 2234 | 0.06 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.06 | Why? |
| CD11 Antigens | 1 | 2020 | 74 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.05 | Why? |
| Actins | 1 | 2021 | 108 | 0.05 | Why? |
| Brain Stem | 1 | 2002 | 131 | 0.05 | Why? |
| Arabidopsis | 1 | 2021 | 88 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2020 | 2309 | 0.05 | Why? |
| Registries | 1 | 2020 | 12327 | 0.05 | Why? |
| Enzyme Activation | 1 | 2021 | 425 | 0.05 | Why? |
| Female | 19 | 2021 | 380317 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.05 | Why? |
| Prospective Studies | 6 | 2021 | 43301 | 0.05 | Why? |
| Heart Failure | 1 | 2021 | 6638 | 0.05 | Why? |
| Influenza, Human | 2 | 2017 | 10779 | 0.05 | Why? |
| Pneumonia | 1 | 2019 | 5652 | 0.05 | Why? |
| Models, Biological | 1 | 2016 | 4907 | 0.05 | Why? |
| Saccharomyces cerevisiae | 1 | 2021 | 339 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Autocrine Communication | 1 | 2018 | 14 | 0.05 | Why? |
| Cerebral Cortex | 1 | 2002 | 276 | 0.05 | Why? |
| Communicable Diseases, Emerging | 1 | 2013 | 2523 | 0.05 | Why? |
| Ampicillin | 1 | 2018 | 73 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2020 | 616 | 0.05 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.05 | Why? |
| Chemokine CCL3 | 1 | 2018 | 103 | 0.05 | Why? |
| Bacterial Capsules | 1 | 2018 | 39 | 0.05 | Why? |
| Toll-Like Receptors | 1 | 2021 | 365 | 0.05 | Why? |
| Toll-Like Receptor 9 | 1 | 2018 | 72 | 0.04 | Why? |
| Adult | 13 | 2021 | 244371 | 0.04 | Why? |
| Membrane Potential, Mitochondrial | 1 | 2018 | 102 | 0.04 | Why? |
| Respiratory Insufficiency | 1 | 2019 | 7301 | 0.04 | Why? |
| Cell Communication | 1 | 2020 | 396 | 0.04 | Why? |
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 88 | 0.04 | Why? |
| Aged | 12 | 2021 | 215776 | 0.04 | Why? |
| Paracrine Communication | 1 | 2018 | 73 | 0.04 | Why? |
| HLA-DR Antigens | 1 | 2020 | 563 | 0.04 | Why? |
| Mice, Inbred BALB C | 2 | 2019 | 5814 | 0.04 | Why? |
| Cell Membrane | 1 | 2003 | 743 | 0.04 | Why? |
| Fatty Acid-Binding Proteins | 1 | 2017 | 93 | 0.04 | Why? |
| Pattern Recognition, Automated | 1 | 2018 | 160 | 0.04 | Why? |
| Papio | 1 | 2017 | 104 | 0.04 | Why? |
| Spectrometry, Fluorescence | 1 | 2017 | 177 | 0.04 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 552 | 0.04 | Why? |
| Male | 15 | 2021 | 367725 | 0.04 | Why? |
| Pulmonary Veins | 1 | 2018 | 146 | 0.04 | Why? |
| Microvessels | 1 | 2021 | 490 | 0.04 | Why? |
| Epithelial Cells | 2 | 2020 | 3508 | 0.04 | Why? |
| Chemokine CCL2 | 1 | 2018 | 389 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2019 | 793 | 0.04 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.04 | Why? |
| Mesocricetus | 1 | 2021 | 1847 | 0.04 | Why? |
| Bronchoalveolar Lavage | 1 | 2019 | 603 | 0.04 | Why? |
| Iatrogenic Disease | 1 | 2018 | 304 | 0.04 | Why? |
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 239 | 0.04 | Why? |
| Antigens, CD | 1 | 2021 | 984 | 0.04 | Why? |
| Blood Cell Count | 1 | 2021 | 1101 | 0.04 | Why? |
| Echocardiography | 2 | 2021 | 3661 | 0.04 | Why? |
| Adenosine Triphosphate | 1 | 2018 | 294 | 0.04 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.04 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.04 | Why? |
| Automation, Laboratory | 1 | 2018 | 536 | 0.04 | Why? |
| Longitudinal Studies | 2 | 2021 | 9893 | 0.04 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.04 | Why? |
| Cell Line | 2 | 2021 | 12040 | 0.04 | Why? |
| Healthy Volunteers | 1 | 2020 | 1444 | 0.03 | Why? |
| Coronavirus NL63, Human | 1 | 2020 | 669 | 0.03 | Why? |
| Acinetobacter baumannii | 1 | 2017 | 378 | 0.03 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2020 | 37182 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2020 | 2689 | 0.03 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.03 | Why? |
| Treatment Outcome | 4 | 2020 | 51732 | 0.03 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2002 | 3395 | 0.03 | Why? |
| Calcium | 1 | 2018 | 708 | 0.03 | Why? |
| Respiratory Tract Infections | 1 | 2013 | 6817 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2020 | 1887 | 0.03 | Why? |
| Africa South of the Sahara | 1 | 2017 | 1335 | 0.03 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.03 | Why? |
| Ventricular Function, Left | 1 | 2021 | 1555 | 0.03 | Why? |
| Coronavirus OC43, Human | 1 | 2020 | 1157 | 0.03 | Why? |
| Interleukin-1beta | 1 | 2017 | 992 | 0.03 | Why? |
| Troponin T | 1 | 2017 | 771 | 0.03 | Why? |
| Coronavirus 229E, Human | 1 | 2020 | 1241 | 0.03 | Why? |
| Klebsiella pneumoniae | 1 | 2017 | 658 | 0.03 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.03 | Why? |
| Adenocarcinoma | 1 | 2018 | 651 | 0.03 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.03 | Why? |
| Stroke Volume | 1 | 2021 | 2153 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.03 | Why? |
| Inflammasomes | 1 | 2017 | 710 | 0.03 | Why? |
| Immune System | 1 | 2020 | 1479 | 0.03 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.03 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.03 | Why? |
| Europe | 2 | 2017 | 12702 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.03 | Why? |
| Neurosurgical Procedures | 1 | 2002 | 1738 | 0.03 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.03 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.02 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.02 | Why? |
| Bronchoscopy | 1 | 2018 | 991 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 896 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Long-Term Care | 1 | 2021 | 2047 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.02 | Why? |
| Phenotype | 1 | 2020 | 4037 | 0.02 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.02 | Why? |
| Swine | 1 | 2018 | 3352 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| Middle East | 1 | 2013 | 1418 | 0.02 | Why? |
| Syndrome | 1 | 2013 | 1310 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2002 | 7268 | 0.02 | Why? |
| Binding Sites | 1 | 2020 | 6201 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Heart | 1 | 2017 | 1791 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2020 | 4155 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.02 | Why? |
| Software | 1 | 2018 | 2501 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Transients and Migrants | 1 | 2017 | 1468 | 0.02 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.02 | Why? |
| Interferon Type I | 1 | 2018 | 2789 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2016 | 3788 | 0.02 | Why? |
| Antibody Formation | 1 | 2018 | 4038 | 0.02 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.02 | Why? |
| Protein Binding | 1 | 2020 | 11430 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Tomography, X-Ray Computed | 2 | 2018 | 25144 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2021 | 8248 | 0.02 | Why? |
| Electrocardiography | 1 | 2017 | 3957 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 7868 | 0.02 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2019 | 6537 | 0.01 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2021 | 6153 | 0.01 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.01 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.01 | Why? |
| Hypertension | 1 | 2021 | 8895 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2003 | 12361 | 0.01 | Why? |
| Travel | 1 | 2017 | 7220 | 0.01 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2017 | 8843 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Public Health | 1 | 2017 | 16359 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2017 | 15909 | 0.01 | Why? |
| Incidence | 1 | 2010 | 25622 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |
| Internet | 1 | 2003 | 6204 | 0.00 | Why? |
| Coronavirus | 1 | 2013 | 18339 | 0.00 | Why? |
| SARS Virus | 1 | 2003 | 13021 | 0.00 | Why? |